Article
Genomewide association analysis on green tea chemoprevention of colorectal adenoma: the importance of SLCO1A2 variants.
Pharmacogenomics - 1 Jan 2025
Stingl J, Scholl C, Steffens M, Koczera P, Muche R, Rohlmann F, Ettrich Th, Seufferlein Th
Abstract excerpt
BACKGROUND: Green tea extract was tested for the secondary prevention of colorectal adenoma in the placebo-controlled MIRACLE trial. Genome-wide screening on adenoma recurrence was performed in n = 550 participants 3 years after randomization to green tea or placebo intake. METHODS: Single Marker Analysis followed by regression analyses was calculated for all 700.078 markers assuming an additive genetic model and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
